為啥FDA還不批novavax，這篇文章說它似乎比輝瑞和莫得納更好

“The most compelling thing that I’ve seen today is the data from Novavax, showing that their protein vaccine can elicit neutralizing antibodies to the prototype strain, to BA.1, BA.2, and BA.5,” said Dr. James Hildreth, president and CEO of Meharry Medical College. “Their data seems more impressive to me than the data presented by either Pfizer or Moderna. I just wonder whether or not it might be timely for the agency to quickly review the data and make a decision to approve the Novavax vaccine.”https://www.marketwatch.com/story/novavax-is-part-of-the-fdas-covid-19-booster-debate-but-its-vaccine-still-hasnt-been-authorized-11656528348